Gyre Therapeutics Inc (GYRE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Gyre Therapeutics Inc   (NASDAQ: GYRE)


Gyre Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Gyre Therapeutics Inc's ROI in the second quarter of 2026?
Gyre Therapeutics Inc recorded a cumulative net loss of $-28 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -21.78%.

Within the Healthcare sector 248 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2432 to 2599.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 26.21 % -3.25 % -13.37 % -7.61 % -3.27 %
Y / Y Net Income Change TTM - - -8.43 % 24.91 % 35.65 %
Investment (TTM) in Millions 190 84 65 179 103
Return On Investment (TTM) -21.78 % -15.02 % 6.8 % 8.32 % 5.99 %
GYRE's Overall Ranking # 2599 # 2432 # 1012 # 655 # 934
Seq. Investment Change TTM 20.2 % 0.15 % -2.98 % 8.07 % -7.86 %
Seq. Net Income Change TTM - - -20.77 % 50.03 % -52.39 %
Net Income (TTM) in Millions -28 -16 7 9 6

GYRE Company Profile >> Back to GYRE Roi Comparisons >> See Annual GYRE Return On Investment



Return On Investment GYRE's Ranking
Within: No.
Industry # 87
Sector # 249
Overall # 2599

Return On Investment Statistics
High Average Low
282.32 %
-20.41 %
-148.15 %
(Sep 30 2023)   (Mar 31 2022)







Financial Statements
Gyre Therapeutics Inc's II. Quarter Investments $ 190 Millions GYRE's Balance sheet
Gyre Therapeutics Inc's II. Quarter Income $ -14 Millions Quarterly GYRE's Income Statement
GYRE's Income by Division See GYRE's Income by Division


GYRE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 184 141 62 12 41
Y / Y Investment Growth 30.59 % 128.32 % 431.36 % -72 % -46.14 %
Net Income in Millions 10 18 -85 -8 -88
Y / Y Net Income Growth -44.8 % - - - -
Annual Return On Investment 5.37 % 12.7 % -138.44 % -70.93 % -211.9 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 5.37 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GYRE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GYRE's Competitors
Subscribers only: Roi for Gyre Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for GYRE's Customers

Other Ratios
GYRE's Roa GYRE's Inventory Turnover Ratio GYRE's Growth Rates GYRE's Dividend Statistics
GYRE's Profitability Ratios GYRE's Asset Turnover Ratio GYRE's Dividend Growth
GYRE's Roe GYRE's Valuation Ratios GYRE's Financial Strength Ratios GYRE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-14T20:17:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.